 |
|
|
| |
When glecaprevir/pibrentasvir ultra-short therapy is enough to eradicate HCV infection
|
| |
| |
EASL 2024 June 5-8 Milan Italy
A. Grassi1,2, N. Celli1, S. Maccariello1, G. Donati1, A. Fabbri1, G. Ballardini1
1Division of Internal Medicine and Hepatology, Infermi Hospital, Rimini, AUSL Romagna, Italy 2Division of Internal Medicine, Cervesi Hospital, Cattolica (RN), AUSL Romagna, Italy
|
| |
|
|
|
|
|
